Month: December 2021

Path integration in normal aging and Alzheimer’s disease

In this review we discuss converging evidence from human and rodent research demonstrating how path integration (PI) is impaired in healthy aging and Alzheimer’s disease (AD), and point to the neural mechanisms that underlie these deficits. Importantly, we highlight that (i) the grid cell network in the entorhinal cortex is crucial for PI in both […]

Published on December 4, 2021

As Sixth State Finds Omicron Cases, Delta Remains Top Coronavirus Threat

The delta variant is still Americans’ leading coronavirus health threat even as reports surface of the omicron strain in a sixth U.S. state on Friday amid concern that winter holidays may further the spread, experts said. Nebraska on Friday reported six confirmed cases of… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]

Published on December 3, 2021

FDA Clears Use of Lilly’s COVID-19 Antibody Therapy for Kids

The U.S. Food and Drug Administration on Friday authorized the use of Eli Lilly’s COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children, including newborns, who are at risk of severe illness. The therapy, bamlanivimab plus etesevimab, was… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on December 3, 2021